...
首页> 外文期刊>Journal of Medicinal Chemistry >Design, synthesis, and evaluation of Phe-Gly mimetics: heterocyclic building blocks for pseudopeptides.
【24h】

Design, synthesis, and evaluation of Phe-Gly mimetics: heterocyclic building blocks for pseudopeptides.

机译:Phe-Gly模拟物的设计,合成和评估:伪肽的杂环构件。

获取原文
获取原文并翻译 | 示例

摘要

Enantiopure heterocyclic Boc-protected Phe-Gly dipeptidomimetics containing 1,3,4-oxadiazole, 1,2,4-oxadiazole, and 1,2,4-triazole ring systems have been synthesized as building blocks in the synthesis of pseudopeptides. Three derivatives (1-3) have the carboxylic acid function directly bound to the heterocyclic ring, and three derivatives (4-6) have an extra methylene group between the heterocyclic ring and the acid function to allow for an increased conformational flexibility. The mimetics were used as Phe-Gly replacements in the biologically active peptides dermorphin (Tyr-D-Ala-Phe-Gly-Tyr-Pro-Ser-NH(2)) and substance P (Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-MetNH(2), SP). The pseudopeptide synthesis was performed using solid-phase methodology on a MBHA-resin using Boc-chemistry. The biological evaluation was performed by testing the micro- and delta-opioid receptor affinities of the dermorphin pseudopeptides and the NK(1) receptor affinities of the SP pseudopeptides. The results showed that all mimetics except 3 were excellent replacements of Phe-Gly in dermorphin since they displayed affinities for the micro-receptor (IC(50) = 12-31 nM) in the same range as dermorphin itself (IC(50) = 6.2 nM). The agonist activity of three pseudopeptides at human micro-receptors was also evaluated. It was shown that the tested compounds retained their agonist activity. The SP pseudopeptides showed considerably lower affinities (IC(50) > 1 microM) for the NK(1) receptor than SP itself (IC(50) = 1.5 nM) indicating that the Phe-Gly replacements prevent the pseudopeptides from adopting bioactive conformations.
机译:含有1,3,4-恶二唑,1,2,4-恶二唑和1,2,4-三唑环系统的对映体杂环Boc保护的Phe-Gly二肽模拟物是伪肽合成中的结构单元。三个衍生物(1-3)具有直接键合到杂环上的羧酸官能团,并且三个衍生物(4-6)在杂环和酸官能团之间具有额外的亚甲基,以提高构象柔韧性。该模拟物用作生物活性肽dermorphin(Tyr-D-Ala-Phe-Gly-Tyr-Pro-Ser-NH(2))和物质P(Arg-Pro-Lys-Pro-Gln的Phe-Gly替代品) -Gln-Phe-Phe-Gly-Leu-MetNH(2),SP)。使用Boc化学方法在MBHA树脂上使用固相方法进行假肽合成。通过测试dermorphin假肽的微阿片受体亲和力和SP假肽的NK(1)受体亲和力来进行生物学评估。结果表明,除3个模拟物外,其他所有模拟物均是dermorphin中Phe-Gly的极佳替代品,因为它们对微受体(IC(50)= 12-31 nM)的亲和力与dermorphin本身(IC(50)= 6.2 nM)。还评估了三种假肽对人微受体的激动活性。结果表明,所测试的化合物保留了其激动剂活性。 SP假肽显示对NK(1)受体的亲和力比SP本身(IC(50)= 1.5 nM)低得多(IC(50)> 1 microM),这表明Phe-Gly替代物阻止了假肽采用生物活性构象。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号